Martin F. Fey - Concepedia

Author

Martin F. Fey

Also Known As

B Thürlimann, Beat Thürlimann, Fey, Martin, Guttormsen, Sissel, J. H. Beer, John Collins, M F Fey, M Fey, M. F Fey, M. F. FEY

298

Publications

14.3K

Citations

H-Index

121

Concepts

All Affiliations

University Hospital of Bern University of Bern Kantonsspital St. Gallen Swiss Group For Clinical Cancer Research European Institute of Oncology

About

Martin F. Fey is an author at University Hospital of Bern specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	84	6.5K
2	Health Sciences	20	23	2.4K
3	Natural Sciences	3	3	91
4	Nursing	1	1	30
5	Public Health	1	1	14

Martin F. Fey

146

Publications

12.4K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia Pierre Fenaux, Claude Chastang, Sylvie Chevret, Blood	1999	743
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial Viviana Galimberti, Bernard F. Cole, Giuseppe Viale, The Lancet Oncology Surgical OncologyBreast OncologyMedicineIbcsg 23-01Breast Cancer	2018	533
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck, Blood	2007	470
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) Bernhard C. Pestalozzi, David Zahrieh, Karen N. Price, Annals of Oncology Neuro-oncologyBreast OncologyCancer RiskCancer EpidemiologyBreast Cancer Patients	2006	409
Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia Bob Löwenberg, Wim van Putten, Matthias Theobald, New England Journal of Medicine	2003	384
Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53 Tobias Grob, Urban Novak, Carine Maisse, Cell Death and Differentiation Transcriptional RegulationSignal TransductionSignaling PathwayCell RegulationMolecular Regulation	2001	334
Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII Diana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch, Journal of Clinical Oncology	2000	294
Induction of Genes Mediating Interferon-dependent Extracellular Trap Formation during Neutrophil Differentiation Sibylla Martinelli, Mirjana Urosevic, Arezoo Daryadel, Journal of Biological Chemistry ImmunologyImmunologic MechanismInnate ImmunityCellular PhysiologyInflammation	2004	283
Risk Factors for Locoregional Recurrence Among Breast Cancer Patients: Results From International Breast Cancer Study Group Trials I Through VII Arne Wallgren, Marco Bonetti, Richard D. Gelber, Journal of Clinical Oncology	2003	272
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience Gilles Berclaz, S. Li, Karen N. Price, Annals of Oncology ObesitySurgical OncologyBody CompositionBreast OncologyMedicine	2004	259

Page 1